{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:27:44Z","timestamp":1715171264782},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T00:00:00Z","timestamp":1425513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10072-015-2137-x","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T09:57:15Z","timestamp":1425463035000},"page":"921-926","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of ubiquitin carboxy-terminal hydrolase-L1 in cerebrospinal fluid with clinical severity in a cohort of patients with Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Satoshi","family":"Nagamine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kabuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,5]]},"reference":[{"issue":"2","key":"2137_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","volume":"32","author":"A McGrogan","year":"2009","unstructured":"McGrogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain\u2013Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 32(2):150\u2013163. doi: 10.1159\/000184748","journal-title":"Neuroepidemiology"},{"issue":"1","key":"2137_CR2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11910-007-0022-6","volume":"7","author":"S Kuwabara","year":"2007","unstructured":"Kuwabara S (2007) Guillain\u2013barre syndrome. Curr Neurol Neurosci Rep 7(1):57\u201362","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Pt 3","key":"2137_CR3","first-page":"597","volume":"118","author":"TW Ho","year":"1995","unstructured":"Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain\u2013Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118(Pt 3):597\u2013605","journal-title":"Brain"},{"issue":"5","key":"2137_CR4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1084\/jem.178.5.1771","volume":"178","author":"N Yuki","year":"1993","unstructured":"Yuki N, Taki T, Inagaki F, Kasama T, Takahashi M, Saito K, Handa S, Miyatake T (1993) A bacterium lipopolysaccharide that elicits Guillain\u2013Barre syndrome has a GM1 ganglioside-like structure. J Exp Med 178(5):1771\u20131775","journal-title":"J Exp Med"},{"issue":"12","key":"2137_CR5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1474-4422(13)70215-1","volume":"12","author":"S Kuwabara","year":"2013","unstructured":"Kuwabara S, Yuki N (2013) Axonal Guillain\u2013Barre syndrome: concepts and controversies. Lancet Neurol 12(12):1180\u20131188","journal-title":"Lancet Neurol"},{"issue":"5","key":"2137_CR6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp-2012-302824","volume":"84","author":"N Shahrizaila","year":"2013","unstructured":"Shahrizaila N, Yuki N (2013) Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 84(5):576\u2013583","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"2137_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp-2011-301882","volume":"83","author":"YA Rajabally","year":"2012","unstructured":"Rajabally YA, Uncini A (2012) Outcome and its predictors in Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry 83(7):711\u2013718","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2137_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-009-0097-x","volume":"256","author":"J Brettschneider","year":"2009","unstructured":"Brettschneider J, Petzold A, Sussmuth S, Tumani H (2009) Cerebrospinal fluid biomarkers in Guillain\u2013Barre syndrome\u2014where do we stand? J Neurol 256(1):3\u201312","journal-title":"J Neurol"},{"issue":"5","key":"2137_CR9","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cell.2005.11.007","volume":"123","author":"SM Nijman","year":"2005","unstructured":"Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123(5):773\u2013786","journal-title":"Cell"},{"issue":"6701","key":"2137_CR10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","volume":"395","author":"E Leroy","year":"1998","unstructured":"Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson\u2019s disease. Nature 395(6701):451\u2013452","journal-title":"Nature"},{"issue":"9","key":"2137_CR11","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1073\/pnas.1222732110","volume":"110","author":"K Bilguvar","year":"2013","unstructured":"Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, Delil S, Caglayan AO, Baranoski JF, Erturk O, Yalcinkaya C, Karacorlu M, Dincer A, Johnson MH, Mane S, Chandra SS, Louvi A, Boggon TJ, Lifton RP, Horwich AL, Gunel M (2013) Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc Natl Acad Sci USA 110(9):3489\u20133494","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2137_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pneurobio.2009.10.020","volume":"90","author":"IN Day","year":"2010","unstructured":"Day IN, Thompson RJ (2010) UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Prog Neurobiol 90(3):327\u2013362. doi: 10.1016\/j.pneurobio.2009.10.020","journal-title":"Prog Neurobiol"},{"issue":"8093","key":"2137_CR13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","volume":"2","author":"RA Hughes","year":"1978","unstructured":"Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2(8093):750\u2013753","journal-title":"Lancet"},{"issue":"10","key":"2137_CR14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddn037","volume":"17","author":"T Kabuta","year":"2008","unstructured":"Kabuta T, Setsuie R, Mitsui T, Kinugawa A, Sakurai M, Aoki S, Uchida K, Wada K (2008) Aberrant molecular properties shared by familial Parkinson\u2019s disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1. Hum Mol Genet 17(10):1482\u20131496","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2137_CR15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neuint.2010.04.015","volume":"57","author":"S Nagamine","year":"2010","unstructured":"Nagamine S, Kabuta T, Furuta A, Yamamoto K, Takahashi A, Wada K (2010) Deficiency of ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) leads to vulnerability to lipid peroxidation. Neurochem Int 57(2):102\u2013110. doi: 10.1016\/j.neuint.2010.04.015","journal-title":"Neurochem Int"},{"issue":"12","key":"2137_CR16","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1212\/WNL.40.12.1900","volume":"40","author":"N Yuki","year":"1990","unstructured":"Yuki N, Yoshino H, Sato S, Miyatake T (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40(12):1900\u20131902","journal-title":"Neurology"},{"issue":"6","key":"2137_CR17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","volume":"49","author":"N Yuki","year":"2001","unstructured":"Yuki N, Yamada M, Koga M, Odaka M, Susuki K, Tagawa Y, Ueda S, Kasama T, Ohnishi A, Hayashi S, Takahashi H, Kamijo M, Hirata K (2001) Animal model of axonal Guillain\u2013Barre syndrome induced by sensitization with GM1 ganglioside. Ann Neurol 49(6):712\u2013720","journal-title":"Ann Neurol"},{"issue":"11","key":"2137_CR18","first-page":"817","volume":"15","author":"H Okuyama","year":"1975","unstructured":"Okuyama H (1975) Mechanism of increase of the cerebrospinal fluid (CSF) protein content in Guillain\u2013Barre syndrome. Study using RISA in evaluation of diffusion within CSF cavity and transport of CSF to circulating plasms. Rinsho Shinkeigaku 15(11):817\u2013826","journal-title":"Rinsho Shinkeigaku"},{"issue":"4","key":"2137_CR19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jtcvs.2011.06.027","volume":"142","author":"GJ Arnaoutakis","year":"2011","unstructured":"Arnaoutakis GJ, George TJ, Wang KK, Wilson MA, Allen JG, Robinson CW, Haggerty KA, Weiss ES, Blue ME, Talbot CC Jr, Troncoso JC, Johnston MV, Baumgartner WA (2011) Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest. J Thorac Cardiovasc Surg 142(4):902\u2013910. doi: 10.1016\/j.jtcvs.2011.06.027 (e901)","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2137_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.21239","volume":"40","author":"A Petzold","year":"2009","unstructured":"Petzold A, Brettschneider J, Jin K, Keir G, Murray NM, Hirsch NP, Itoyama Y, Reilly MM, Takeda A, Tumani H (2009) CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain\u2013Barre syndrome. Muscle Nerve 40(1):42\u201349","journal-title":"Muscle Nerve"},{"issue":"2","key":"2137_CR21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/WNL.51.2.394","volume":"51","author":"ME Massaro","year":"1998","unstructured":"Massaro ME, Rodriguez EC, Pociecha J, Arroyo HA, Sacolitti M, Taratuto AL, Fejerman N, Reisin RC (1998) Nerve biopsy in children with severe Guillain\u2013Barre syndrome and inexcitable motor nerves. Neurology 51(2):394\u2013398","journal-title":"Neurology"},{"issue":"5","key":"2137_CR22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10072-012-1092-z","volume":"34","author":"XK Wang","year":"2013","unstructured":"Wang XK, Zhang HL, Meng FH, Chang M, Wang YZ, Jin T, Mix E, Zhu J (2013) Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain\u2013Barre syndrome. Neurol Sci 34(5):655\u2013661","journal-title":"Neurol Sci"},{"issue":"1","key":"2137_CR23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CCM.0b013e3181b788ab","volume":"38","author":"L Papa","year":"2010","unstructured":"Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ 3rd, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, Heaton SC, Hannay HJ, Demery JA, Brophy GM, Layon J, Robertson CS, Hayes RL, Wang KK (2010) Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit Care Med 38(1):138\u2013144. doi: 10.1097\/CCM.0b013e3181b788ab","journal-title":"Crit Care Med"},{"key":"2137_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2377-12-85","volume":"12","author":"S Mondello","year":"2012","unstructured":"Mondello S, Palmio J, Streeter J, Hayes RL, Peltola J, Jeromin A (2012) Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure. BMC Neurol 12:85. doi: 10.1186\/1471-2377-12-85","journal-title":"BMC Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-015-2137-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-015-2137-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-015-2137-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:19:06Z","timestamp":1559107146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-015-2137-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,5]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1007\/s10072-015-2137-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,5]]}}}